Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 164, 139-146
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31500153)
- China Postdoctoral Science Foundation (2018M633026)
This publication has 37 references indexed in Scilit:
- Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enterovirusesCell Discovery, 2019
- A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in miceVaccine, 2018
- Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015Journal of Clinical Virology, 2017
- Production of Biopharmaceuticals in E. coli: Current Scenario and Future PerspectivesJournal of Microbiology and Biotechnology, 2015
- Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwideExpert Review of Anti-infective Therapy, 2015
- Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infectionVaccine, 2013
- Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in FinlandJournal of Clinical Virology, 2010
- Recombinant protein expression in Escherichia coliCurrent Opinion in Biotechnology, 1999
- Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopyNature, 1997
- Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopyCell, 1994